PATENT CLAIM ANALYSIS

Application Number: 16387937
Application Type: Utility
Filing Date: 2019-04
Publication Date: 2019-08
Patent Classification: ["514", "210190"]

Abstract:
The present invention relates to inhibitors of histone deacetylases, in particular HDAC8, that are useful for the treatment of cancer and other diseases and disorders, as well as the synthesis and applications of said inhibitors.

Claim (Index 12):
The compound of  claim 1 , wherein het is 1,3-dihydro-2H-benzo[d]imidazole-2-one substituted with one or more R d .

Metadata:
- Claim Count in Document: 8.0
- Percentile: 100.0
- Lexical Diversity: 1.3
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15925559', '15067605', '11969975', '13129843', '13612715']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8047016223504851
- 35 USC 102 Novelty (BERT): 0.5727013692806834
- Combined Prediction Score: 0.781501597043505
- Mean Citation Score: 404.503706
- Max Citation Score: 482.1481
- Similarity Product: 347.7025588163138

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test